New Ray Medicine International Holding Limited

SEHK:6108 Stock Report

Market Cap: HK$85.3m

New Ray Medicine International Holding Past Earnings Performance

Past criteria checks 0/6

New Ray Medicine International Holding's earnings have been declining at an average annual rate of -23%, while the Healthcare industry saw earnings growing at 5.1% annually. Revenues have been declining at an average rate of 17.7% per year.

Key information

-23.0%

Earnings growth rate

-23.0%

EPS growth rate

Healthcare Industry Growth11.3%
Revenue growth rate-17.7%
Return on equity-4.6%
Net Margin-44.2%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Lacklustre Performance Is Driving New Ray Medicine International Holding Limited's (HKG:6108) 34% Price Drop

Jan 26
Lacklustre Performance Is Driving New Ray Medicine International Holding Limited's (HKG:6108) 34% Price Drop

There's Reason For Concern Over New Ray Medicine International Holding Limited's (HKG:6108) Price

Jun 08
There's Reason For Concern Over New Ray Medicine International Holding Limited's (HKG:6108) Price

We're Keeping An Eye On New Ray Medicine International Holding's (HKG:6108) Cash Burn Rate

Mar 29
We're Keeping An Eye On New Ray Medicine International Holding's (HKG:6108) Cash Burn Rate

Revenue & Expenses Breakdown

How New Ray Medicine International Holding makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SEHK:6108 Revenue, expenses and earnings (HKD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2350-22330
30 Sep 2377-46350
30 Jun 23104-70320
31 Mar 2397-74350
31 Dec 2290-78440
30 Sep 22135-52420
30 Jun 22180-25390
31 Mar 22258-14370
31 Dec 21335-3360
30 Sep 21307-17460
30 Jun 21278-32570
31 Mar 21206-51560
31 Dec 20133-70560
30 Sep 20133-71510
30 Jun 20133-73460
31 Mar 20126-58460
31 Dec 19119-44460
30 Sep 19188-16460
30 Jun 1925811460
31 Mar 1931522460
31 Dec 1837233470
30 Sep 18326-3450
30 Jun 18280-38440
31 Mar 18258-72440
31 Dec 17235-105430
30 Sep 17241-89430
30 Jun 17247-72430
31 Mar 17236-46420
31 Dec 16225-20410
30 Sep 16226-11390
30 Jun 16227-1360
31 Mar 162507380
31 Dec 1525315350
30 Sep 1525726310
30 Jun 1524934260
31 Mar 1523334210
31 Dec 1420730190
30 Sep 1420833180
30 Jun 1419727160
31 Mar 1418224120
31 Dec 1319317110
30 Sep 131616100
30 Jun 131695100

Quality Earnings: 6108 is currently unprofitable.

Growing Profit Margin: 6108 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 6108 is unprofitable, and losses have increased over the past 5 years at a rate of 23% per year.

Accelerating Growth: Unable to compare 6108's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 6108 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (7.8%).


Return on Equity

High ROE: 6108 has a negative Return on Equity (-4.62%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.